Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 83,491 shares at $105.56 ($9.8M) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($9.8M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.56 | 2,685 | $283K | 2.9% |
| 2 | $105.56 | 2,685 | $283K | 2.9% |
| 3 | $106.51 | 91 | $10K | 0.1% |
| 4 | $107.57 | 424 | $46K | 0.5% |
| 5 | $110.00 | 6,800 | $748K | 7.7% |
| 6 | $114.17 | 23,500 |
| $2.7M |
| 27.5% |
| 7 | $120.25 | 22,500 | $2.7M | 27.7% |
| 8 | $120.64 | 6,140 | $741K | 7.6% |
| 9 | $120.64 | 6,140 | $741K | 7.6% |
| 10 | $122.16 | 6,222 | $760K | 7.8% |
| 11 | $122.16 | 6,222 | $760K | 7.8% |
| 12 | $122.67 | 82 | $10K | 0.1% |
| Total | $117.02 avg | 83,491 | $9.8M | 100% |
| Filing → |
| TMDX | SELL | 2024-10-17 | $2.1M | — | Filing → |
| TMDX | SELL | 2024-09-17 | $2.6M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |